Connect with us

Berita

Kalemdiklat Polri Hadiri Penutupan Diklat Integrasi Kampus Kebangsaan TNI dan Polri TA 2022

Published

on

SURABAYA – Pelaksanaan Diklat Integrasi Kampus Kebangsaan TNI dan Polri TA 2022 selama tujuh hari mulai tanggal 9-16 Desember 2022 dengan peserta Diklat sebanyak 476 orang terdiri dari Maba TNI 356 orang, Siswa Polri 100 orang Maba Kowal 20 orang resmi dinyatakan selesai.

Kalemdiklat Polri Komjen Pol Rycko Amelza Dahniel memimpin Pelaksanaan Upacara Penutupan Diklat Integrasi Kampus Kebangsaan TNI dan Polri TA 2022 tersebut pada Jumat (16/12/2022) di Lapangan Laut Maluku Kodiklatal Surabaya.

Komjen Pol Rycko Amelza Dahniel, menjelaskan, bersama sama dengan Polri melaksanakan pendidikan integrasi pada seluruh peserta anak didik.

“Kami mohon bantuan aparatur pemerintah daerah pada para tokoh, terutama pada tokoh agama untuk sama sama memberikan dorongan, memberikan penguatan kepada peserta didik TNI dan Polri,” ungkapnya.

“Tugas yang mereka emban di samping tidak ringan juga merupakan tugas yang sangat mulia. Yaitu menjaga keutuhan negeri kita yang sangat majemuk ini,” kata Komjen Pol Rycko Amelza Dahniel.

Ia menegaskan, kemajemukan itu merupakan keniscayaan daripada negeri ini, negeri kebangsaan, negeri yang dibangun dari berbagai perbedaan.

“Dan kita pahami perbedaan itu memiliki potensi konflik,” tutur Komjen Pol Rycko.

Ia juga meminta untuk mengelola Perbedaan dengan baik. Jika diibaratkan kemajemukan itu sebagai sebuah mozaik, lanjut Komjen Pol Rycko maka mozaik ini apabila disatukan akan menjadi indah.

“Keindahan daripada berbagai perbedaan mozaik itu harus diikat dengan bingkai yang kuat dengan perekat yang kuat dan perekat itu TNI dan Polri,” tambahnya.

Oleh karena itu, ia menegaskan Perbedaan harus ada alat, harus ada organ yang diberi kepercayaan untuk menjaga perbedaan itu. Untuk menjadi perekatnya untuk menjadi bingkainya.

Oleh karena itu bingkainya tidak boleh pecah, tidak boleh retak apalagi mudah dipecah bela, mudah diadu domba.

“Kita pasti bisa menjaga negeri kita yang baik ini, negeri kita yang kita cintai secara bersama sama. Tolong kami diingatkan, anak anak kami diingatkan kami terus diberikan bimbingan melalui ajaran agama yang baik untuk mencintai negerinya dan rakyatnya,” tutup dia.

Usai upacara ditandai dengan penanggalan tanda peserta Diklat Integrasi Kampus Kebangsaan TNI dan Polri TA 2022 oleh Kalemdiklat Polri secara simbolis.

Kegiatan dilanjutkan dengan penampilan yel-yel oleh peserta Diklat Integrasi Kampus Kebangsaan TNI dan Polri TA 2022. Yel-yel tersebut menunjukkan bentuk sinergitas dan kolaborasi antara TNI Polri dalam menjaga keutuhan NKRI.

Hadir dalam kegiatan tersebut, Waka Polda Jawa Timur, Brigjen Pol Slamet Hadi Supraptoyo,, Dankakodiklatal, Wadankodiklatal, PJU Lemdiklat Polri, Seklem AAL, Kapoksahli Koarmada II, Aspers Kasdam V/Brawijaya, PJU Kodiklatal, PJU Polda Jatim, PB SDM Prov. Jatim, Wadanpasmar 2, Aspotmar Lantamal V, Kadisops Danlanud Muldjono, Kapolres Pelabuhan Tj. Perak, Ketua PGI Jatim, Ketua Walubi Jatim, PBNU Jatim serta PDHI Jatim. (*)

Continue Reading
Click to comment

Leave a Reply

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

tc-check-test1

Published

on

tc-manager precheck test1 – https://test1.com

Continue Reading

Trending